Adenosine stress CMR T1-mapping detects early microvascular dysfunction in patients with type 2 diabetes mellitus without obstructive coronary artery disease

[1]  M. Robson,et al.  Adenosine Stress and Rest T1 Mapping Can Differentiate Between Ischemic, Infarcted, Remote, and Normal Myocardium Without the Need for Gadolinium Contrast Agents , 2016, JACC. Cardiovascular imaging.

[2]  William T. Clarke,et al.  Cardiac energetics, oxygenation, and perfusion during increased workload in patients with type 2 diabetes mellitus , 2015, European heart journal.

[3]  E. Nagel,et al.  Is Myocardial Native T1 the One Answer for All? , 2016, JACC. Cardiovascular imaging.

[4]  Matthew D. Robson,et al.  Systolic ShMOLLI myocardial T1-mapping for improved robustness to partial-volume effects and applications in tachyarrhythmias , 2015, Journal of Cardiovascular Magnetic Resonance.

[5]  G. Novo,et al.  Coronary microvascular dysfunction in patients with diabetes, hypertension and metabolic syndrome. , 2015, International journal of cardiology.

[6]  Ornella Rimoldi,et al.  Coronary microvascular dysfunction: mechanisms and functional assessment , 2015, Nature Reviews Cardiology.

[7]  J. Francis,et al.  Adenosine stress native T1 mapping in severe aortic stenosis: evidence for a role of the intravascular compartment on myocardial T1 values , 2014, Journal of Cardiovascular Magnetic Resonance.

[8]  E. Nagel,et al.  Coronary microvascular dysfunction in overt diabetic cardiomyopathy , 2014 .

[9]  S. Neubauer,et al.  Structural and Metabolic Effects of Obesity on the Myocardium and the Aorta , 2014, Obesity Facts.

[10]  S. Plein,et al.  The microvascular effects of insulin resistance and diabetes on cardiac structure, function, and perfusion: a cardiovascular magnetic resonance study , 2014, European heart journal cardiovascular Imaging.

[11]  M. Robson,et al.  Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement , 2013, Journal of Cardiovascular Magnetic Resonance.

[12]  Stefan Neubauer,et al.  T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. , 2013, JACC. Cardiovascular imaging.

[13]  M. Robson,et al.  T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. , 2013, JACC. Cardiovascular imaging.

[14]  R. Hayes,et al.  Association of obesity with cardiovascular disease mortality in the PLCO trial. , 2013, Preventive medicine.

[15]  M. Robson,et al.  Blunted Myocardial Oxygenation Response During Vasodilator Stress in Patients With Hypertrophic Cardiomyopathy , 2013, Journal of the American College of Cardiology.

[16]  S. K. White,et al.  Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI , 2013, Journal of Cardiovascular Magnetic Resonance.

[17]  J. Francis,et al.  Effects of weight loss on myocardial energetics and diastolic function in obesity , 2013, The International Journal of Cardiovascular Imaging.

[18]  R. Blankstein,et al.  Association Between Coronary Vascular Dysfunction and Cardiac Mortality in Patients With and Without Diabetes Mellitus , 2012, Circulation.

[19]  M. Robson,et al.  Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance , 2012, Journal of Cardiovascular Magnetic Resonance.

[20]  J. Francis,et al.  The Effect of Obesity and Weight Loss on Aortic Pulse Wave Velocity as Assessed by Magnetic Resonance Imaging , 2010, Obesity.

[21]  Stefan Neubauer,et al.  Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold , 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[22]  F. Crea,et al.  Primary Coronary Microvascular Dysfunction: Clinical Presentation, Pathophysiology, and Management , 2010, Circulation.

[23]  R. Rubinshtein,et al.  Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham score. , 2010, European heart journal.

[24]  R. Kronmal,et al.  The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2010, JACC. Cardiovascular imaging.

[25]  Jie Zheng,et al.  Roles of myocardial blood volume and flow in coronary artery disease: an experimental MRI study at rest and during hyperemia , 2010, European Radiology.

[26]  E. Abel,et al.  Diabetic cardiomyopathy, causes and effects , 2010, Reviews in Endocrine and Metabolic Disorders.

[27]  S. Abbara.  SCCT guidelines for performance of coronary computed tomographic angiography: A report of the Society of Cardiovascular Computed Tomography Guidelines Committee , 2010 .

[28]  Daniel C. Lee,et al.  Quantification of absolute myocardial blood flow by magnetic resonance perfusion imaging. , 2009, JACC. Cardiovascular imaging.

[29]  Bunyen Teng,et al.  Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology. , 2009, Handbook of experimental pharmacology.

[30]  R. Sacco,et al.  Association between diabetes mellitus and left ventricular hypertrophy in a multiethnic population. , 2008, The American journal of cardiology.

[31]  J. Francis,et al.  Operator induced variability in left ventricular measurements with cardiovascular magnetic resonance is improved after training. , 2007, Journal of Cardiovascular Magnetic Resonance.

[32]  S. Schoenberg,et al.  Cardiac magnetic resonance perfusion imaging for the functional assessment of coronary artery disease: a comparison with coronary angiography and fractional flow reserve. , 2006, European heart journal.

[33]  F. Villarreal,et al.  The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[34]  David C. Sheridan,et al.  Resting Myocardial Blood Flow Is Impaired in Hibernating Myocardium: A Magnetic Resonance Study of Quantitative Perfusion Assessment , 2005, Circulation.

[35]  D. Bell.  Heart failure: the frequent, forgotten, and often fatal complication of diabetes. , 2003, Diabetes care.

[36]  E. Fleck,et al.  Magnetic Resonance Perfusion Measurements for the Noninvasive Detection of Coronary Artery Disease , 2003, Circulation.

[37]  S. Silver,et al.  Heart Failure , 1937, The New England journal of medicine.

[38]  M. Taşkıran,et al.  Decreased myocardial perfusion reserve in diabetic autonomic neuropathy. , 2002, Diabetes.

[39]  E. McVeigh,et al.  Phase‐sensitive inversion recovery for detecting myocardial infarction using gadolinium‐delayed hyperenhancement † , 2002, Magnetic resonance in medicine.

[40]  H. Keen,et al.  Mortality and causes of death in the WHO multinational study of vascular disease in diabetes , 2001, Diabetologia.

[41]  Jennifer Y. Liu,et al.  Glycemic Control and Heart Failure Among Adult Patients With Diabetes , 2001, Circulation.

[42]  R. Holman,et al.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.

[43]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[44]  D. Levy,et al.  Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). , 1991, The American journal of cardiology.

[45]  W. Kannel,et al.  Diabetes and cardiovascular disease. The Framingham study. , 1979, JAMA.

[46]  P. McNamara,et al.  Morbidity and Mortality in Diabetics In the Framingham Population: Sixteen Year Follow-up Study , 1974, Diabetes.